🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07366138
Recruiting Not applicable

Ultrasound-Guided External Oblique Intercostal Plane Block Versus Subcostal Transversus Abdominis Plane Block For Perioperative Analgesia in Laparoscopic Sleeve Gastrectomy

NCT07366138 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-11-01
Last updated
2026-01-26

Condition(s) studied

UltrasoundExternal Oblique Intercostal Plane BlockSubcostal Transversus Abdominis Plane BlockPerioperative AnalgesiaLaparoscopic Sleeve Gastrectomy

Investigational drug(s) / intervention(s)

External oblique intercostal plane blockSubcostal transversus abdominis plane block

External oblique intercostal plane block: Patients will receive an ultrasound-guided bilateral external oblique intercostal plane (EOIP) block using 20 mL of 0.25% bupivacaine in each side after induction of anesthesia and prior to surgical incision.

Subcostal transversus abdominis plane block: Patients will receive a bilateral subcostal transversus abdominis plane (TAP) block using 20 mL of 0.25% bupivacaine in each side, under ultrasound guidance and identical conditions.

Study summary

This study aims to compare the analgesic efficacy, duration of analgesia, and overall opioid consumption between the external oblique intercostal plane (EOIP) block and subcostal transversus abdominis plane (TAP) block in patients undergoing laparoscopic sleeve gastrectomy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Age from 18 to 65 years. * Both genders. * American Society of Anesthesiologists (ASA) class I or II * Body mass index (BMI) between 30-50 kg/m². * Scheduled for elective laparoscopic sleeve gastrectomy under general anesthesia. * Written informed consent from patients or surrogate decision makers. Exclusion Criteria: * Patient refusal. * Allergy to local anesthetics. * Coagulation disorders or anticoagulant therapy. * Local infection or scar at the injection site. * Severe hepatic or renal dysfunction. * Chronic opioid use or psychiatric illness interfering with pain assessment. * Conversion to open surgery or intraoperative complications requiring re-exploration.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Benha University Banhā Benha Recruiting

More Benha University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07366138 on ClinicalTrials.gov ↗ ← All trials in Egypt